PUBLISHER: The Business Research Company | PRODUCT CODE: 1942529
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942529
Cardiovascular devices play a crucial role in the monitoring and management of irregular heartbeats and heart rhythm disorders.
The cardiovascular devices market encompasses various key categories, including cardiovascular surgery devices and equipment, cardiac rhythm management (CRM) devices and equipment, interventional cardiology devices and equipment, defibrillator devices and equipment, peripheral vascular devices and equipment, prosthetic heart valve devices and equipment, electrophysiology devices and equipment, as well as cardiac assist devices and equipment. Defibrillators are instrumental devices that restore a normal heartbeat by delivering an electric pulse or shock to the heart. They are utilized to prevent or correct arrhythmias, which involve irregular, slow, or fast heartbeats. The sources of funding for these devices can be either public or private, while the products used include instruments/equipment and disposables. These devices serve a range of end-users, including hospitals and clinics, diagnostic laboratories, and other healthcare facilities.
Tariffs are impacting the cardiovascular devices market by increasing costs of imported stents, catheters, implantable devices, imaging systems, and specialized surgical equipment. Hospitals and specialty cardiac centers in North America and Europe are most affected due to reliance on imported high-value devices, while Asia-Pacific faces higher production and export costs. These tariffs are increasing procedural costs and influencing purchasing decisions. At the same time, they are encouraging regional manufacturing, domestic device innovation, and diversification of cardiovascular device supply chains.
The cardiovascular devices market research report is one of a series of new reports from The Business Research Company that provides cardiovascular devices market statistics, including cardiovascular devices industry global market size, regional shares, competitors with a cardiovascular devices market share, detailed cardiovascular devices market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular devices industry. This cardiovascular devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cardiovascular devices market size has grown strongly in recent years. It will grow from $72.22 billion in 2025 to $76.6 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, expansion of interventional cardiology procedures, improvements in surgical techniques, growing availability of cardiac care infrastructure, increased use of implantable cardiac devices.
The cardiovascular devices market size is expected to see strong growth in the next few years. It will grow to $100.37 billion in 2030 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to increasing demand for structural heart interventions, rising adoption of AI-assisted cardiac diagnostics, expansion of outpatient cardiovascular procedures, growing investments in next-generation cardiovascular devices, continuous innovation in biocompatible and smart materials. Major trends in the forecast period include increasing adoption of minimally invasive cardiovascular devices, rising use of transcatheter therapies, growing integration of advanced imaging-guided interventions, expansion of remote cardiac monitoring solutions, enhanced focus on device miniaturization and precision.
The rising prevalence of cardiovascular disorders is expected to drive growth in the cardiovascular device market in the coming years. Cardiovascular disorders include medical conditions affecting the heart and blood vessels, encompassing a range of diseases involving the circulatory system. This prevalence is increasing due to factors such as aging populations, sedentary lifestyles, poor diet, and rising rates of hypertension and diabetes. The cardiovascular device market supports this trend by providing devices that assist heart function and maintain blood flow in patients with weakened or failing hearts. For instance, in January 2024, according to the American Heart Association, a U.S.-based nonprofit organization, the age-adjusted death rate from cardiovascular disease rose to 233.3 per 100,000, up 4.0% from 224.4 per 100,000 in 2023. Therefore, the increasing prevalence of cardiovascular disorders is fueling the cardiovascular device market.
The growth of the cardiovascular device market is further supported by rising healthcare expenditure. Healthcare expenditure refers to the total financial resources spent on medical treatments, hospital care, medications, and public health initiatives by governments, businesses, and individuals. The demand for healthcare spending is rising due to the growing prevalence of chronic diseases, which often require long-term and costly treatment. Higher healthcare expenditure enables the adoption of advanced cardiovascular treatment technologies, improves access to life-saving procedures, supports better hospital infrastructure, and facilitates early diagnosis and high-quality patient care. For example, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure increased by 5.6% in nominal terms in 2023, representing a 0.9% rise compared to 2022. Consequently, growing healthcare expenditure is driving the cardiovascular device market.
Leading companies in the cardiovascular devices market are focusing on developing advanced interventional solutions, such as drug-coated balloon catheters, to address complex coronary conditions and improve long-term outcomes. A drug-coated balloon catheter is a minimally invasive device that dilates a narrowed coronary artery segment while simultaneously delivering an antiproliferative drug, such as paclitaxel, to the arterial wall. This helps prevent restenosis without leaving a permanent scaffold. For instance, in March 2024, Boston Scientific, a U.S.-based medical device company, received U.S. FDA approval for its Agent drug-coated balloon catheter, the first of its kind for treating coronary in-stent restenosis (ISR). The device demonstrated significant efficacy in reducing the recurrence of vessel narrowing in a study of 480 patients, offering interventional cardiologists a non-stent alternative for ISR management.
Major companies operating in the cardiovascular devices market are Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences Corporation, Johnson & Johnson, Terumo Corporation, Getinge AB, Teleflex Incorporated, Becton Dickinson and Company, Siemens Healthineers AG, Fresenius SE & Co. KGaA, GE HealthCare Technologies Inc., Stryker Corporation, B. Braun Medical Pvt. Ltd., Baxter International Inc., Fujifilm Holdings Corporation, Canon Medical Systems Corporation, MicroPort Scientific America Inc., W. L. Gore & Associates Inc., AngioDynamics Inc., CryoLife Inc., Endologix LLC, Lombard Medical Limited, Avinger Inc., Abiomed Inc., Biosensors International Group Ltd., Biotronik SE & Co. KG, CeloNova BioSciences Inc., LeMaitre Vascular Inc.
North America was the largest region in the global cardiovascular devices market in 2025. Western Europe was the second largest region in the global cardiovascular devices market. Africa. was the smallest region in the global cardiovascular devices market. The regions covered in the cardiovascular devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cardiovascular devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The cardiovascular devices market consists of sales of biventricular devices, and implantable cardiac loop recorders that are used for monitoring and treatment of cardiovascular disorders. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cardiovascular Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cardiovascular devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cardiovascular devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiovascular devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.